title: Status epilepticus.
abstract: Status epilepticus (SE) in adults is a state of continuous seizures lasting more than 5 minutes, or rapidly recurrent seizures without regaining consciousness. The overall US and European estimated crude incidence rate of SE ranges from 6.8 to 41/100,000/yr. The etiologies of SE include primary central nervous system pathologies and systemic disorders. The two basic mechanisms involved in the genesis of SE are an excess of excitatory activity and a loss of normal inhibitory neurotransmission. Mortality associated with SE can be as high as 26% for the average adult. Early recognition and treatment are important for improving the chances for a good outcome. The first line of treatment is an intravenous benzodiazepine, with lorazepam being the current preferred agent. All patients with SE who remain with altered awareness 20 to 30 minutes after cessation of clinical seizures should undergo electroencephalographic studies, because up to 20% of patients without clinical evidence of seizures after initial treatment can have nonconvulsive SE.
authors: Division of Vascular Neurology and Neurocritical Care, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.
authors: Eliahu S
authors: ES
authors: Feen
authors: Eric M
authors: EM
authors: Bershad
authors: Jose I
authors: JI
authors: Suarez
mesh_terms: D000465:Algorithms; D001569:Benzodiazepines / Q000627:therapeutic use; D004569:Electroencephalography; D006801:Humans; D015994:Incidence; D011379:Prognosis; D012307:Risk Factors; D013226:Status Epilepticus / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy
chemical_list: D001569:Benzodiazepines